Maze Therapeutics (MAZE) Stock Price
Maze Therapeutics Price
The consensus 12-month price target for Maze Therapeutics is 80.50 USD, about 176.4% above where the stock trades today. Of 18 analysts, 17 rate the stock a buy — an overall Buy consensus.
Maze Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Maze Therapeutics business model & stock analysis
Frequently asked questions about Maze Therapeutics
Analysts currently set an average price target of 80.50 USD for the Maze Therapeutics stock (median: 80.50 USD), implying +176.4 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the Maze Therapeutics stock: 17 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Maze Therapeutics to generate revenue of 20.00 M USD and earnings per share of -3.10 USD.
Converted at the current exchange rate, the Maze Therapeutics share trades at 25.94 EUR (29.12 USD).
The expected revenue of Maze Therapeutics is 20.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Maze Therapeutics is -133.26 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Maze Therapeutics is currently -9.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Maze Therapeutics stock.
The price-to-sales ratio (P/S) of Maze Therapeutics is currently 62.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Maze Therapeutics stock.
The Eulerpool Quality Score for Maze Therapeutics is 1/10.
The ISIN of Maze Therapeutics is US5787841007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Maze Therapeutics is MAZE. The ticker symbol is used to trade Maze Therapeutics shares on the stock exchange.
Maze Therapeutics stock
Maze Therapeutics Peer Group
All fundamentals and in-depth analysis of Maze Therapeutics
Our stock analysis for Maze Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Maze Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.